Trimeris' P2P Acquisition

Trimeris raised a round of funding on June 23, 2011. Investors include Synageva BioPharma.

Trimeris is a development stage, biopharmaceutical company engaged in the discovery and development of novel therapeutic agents that block viral infection by inhibiting viral fusion with host cells. T…

Articles about Trimeris' P2P Acquisition: